Pages that link to "Q64354792"
Jump to navigation
Jump to search
The following pages link to Bjørnar Gilje (Q64354792):
Displaying 32 items.
- The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients (Q26782449) (← links)
- Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome (Q34284264) (← links)
- Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients (Q34468675) (← links)
- The potential of cytokeratin 20 and mucin 2 mRNA as metastasis markers in regional lymph nodes of colon cancer patients investigated by quantitative RT-PCR. (Q34913935) (← links)
- Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells (Q36388852) (← links)
- High-fidelity DNA polymerase enhances the sensitivity of a peptide nucleic acid clamp PCR assay for K-ras mutations (Q38290037) (← links)
- miRNA expression profiling for identification of potential breast cancer biomarkers (Q39347477) (← links)
- Detection of occult metastases in sentinel lymph nodes from colon cancer patients by K-ras mutation peptide nucleic acid clamp PCR. (Q39702228) (← links)
- Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer (Q40149888) (← links)
- MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment (Q41822137) (← links)
- Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach (Q46675015) (← links)
- Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer. (Q47562193) (← links)
- Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics (Q50131211) (← links)
- The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer. (Q52688050) (← links)
- Weekly versus 3-weekly cabazitaxel for the treatment of castration-resistant prostate cancer: A randomised phase II trial (ConCab). (Q53692388) (← links)
- Comparison of a PNA clamp PCR and an ARMS/Scorpion PCR assay for the detection of K-ras mutations. (Q54325730) (← links)
- Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients. (Q54408234) (← links)
- Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients. (Q54500317) (← links)
- A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow. (Q54512572) (← links)
- Next-of-kin involvement in improving hospital cancer care quality and safety - a qualitative cross-case study as basis for theory development. (Q55006436) (← links)
- Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer (Q58607799) (← links)
- Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy (Q61631846) (← links)
- Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients (Q61631850) (← links)
- Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients (Q80305517) (← links)
- Measuring next of kin satisfaction with hospital cancer care: Using a mixed-method approach as basis for improving quality and safety (Q89567061) (← links)
- Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients (Q91380204) (← links)
- The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer (Q92869759) (← links)
- Developing a Next-of-Kin Involvement Guide in Cancer Care-Results From a Consensus Process (Q98245007) (← links)
- Effects of replacing PSA with Stockholm3 for diagnosis of clinically significant prostate cancer in a healthcare system - the Stavanger experience (Q98285286) (← links)
- Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen (Q103737314) (← links)
- Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study (Q112559138) (← links)
- Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing (Q112703571) (← links)